Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced q-T prolongation.

Louise W Kao1, R Brent Furbee

  • 1Department of Emergency Medicine, Indiana University School of Medicine, Indianapolis, IN 46206, USA. lkao@clarian.org

The Medical Clinics of North America
|October 18, 2005
PubMed
Summary

Certain medications can prolong the Q-T interval, increasing the risk of Torsade de Pointes (TdP) and sudden cardiac death. Clinicians must carefully assess patient and drug factors to mitigate these risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carbon Monoxide Toxicity.

Emergency medicine clinics of North America·2022
Same author

Acute Cytotoxic Cerebellar Edema Subsequent to Fentanyl Patch Intoxication in an Infant.

Case reports in critical care·2021
Same author

Cardiac Toxicity from Intentional Ingestion of Pong-Pong Seeds (Cerbera Odollam).

The Journal of emergency medicine·2018
Same author

Primary meningococcal arthritis leading to Neisseria meningitidies purpura fulminans.

The western journal of emergency medicine·2013
Same author

Benzodiazepine-associated atrioventricular block.

American journal of therapeutics·2010
Same author

Calcium channel blocker toxicity.

Pediatric emergency care·2009

Area of Science:

  • Cardiology
  • Pharmacology
  • Electrophysiology

Background:

  • Drug-induced Q-T prolongation affects cardiac repolarization via potassium ion channel alterations.
  • This condition is linked to Torsade de Pointes (TdP), a potentially fatal ventricular arrhythmia.
  • Recent regulatory actions highlight the clinical significance of Q-T prolongation.

Purpose of the Study:

  • To review the mechanisms and risk factors associated with drug-induced Q-T prolongation.
  • To emphasize the clinical implications of Q-T prolongation and TdP.
  • To guide clinicians in managing medication risks related to Q-T interval.

Main Methods:

  • Review of existing literature on drug-induced Q-T prolongation.
  • Analysis of the pathophysiology of cardiac repolarization abnormalities.
  • Examination of patient-specific and medication-related risk factors.

Main Results:

  • Drug therapy can alter cardiac potassium currents, leading to Q-T prolongation.
  • Both congenital and acquired Q-T prolongation increase the risk of TdP.
  • Individual risk is influenced by a combination of patient and medication factors.

Conclusions:

  • Clinicians must be vigilant about prescribing drugs that may prolong the Q-T interval.
  • Careful risk-benefit assessment is crucial when using medications known to affect Q-T duration.
  • Awareness of drug-induced Q-T prolongation is essential for preventing adverse cardiac events.

Related Experiment Videos